National Fisheries Institute; Filing of Food Additive Petition; Amendment, 47592-47593 [E9-22008]
Download as PDF
<![CDATA[
srobinson on DSKHWCL6B1PROD with NOTICES
47592
Federal Register / Vol. 74, No. 178 / Wednesday, September 16, 2009 / Notices
Contact Person: Denise Wiesch, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3150,
MSC 7770, Bethesda, MD 20892, (301) 435–
0684, wieschd@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Behavioral Medicine, Interventions and
Outcomes Study Section.
Date: October 5–6, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 1000
Aliceanna Street, Baltimore, MD 21202.
Contact Person: Lee S. Mann, JD, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7848, Bethesda, MD 20892, 301–435–
0677, mannl@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Arthritis, Connective Tissue and Skin Study
Section.
Date: October 5–6, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Aftab A. Ansari, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, (301) 594–
6376, ansaria@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Adult Psychopathology and Disorders
of Aging Study Section.
Date: October 5–6, 2009.
Time: 8:30 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: InterContinental Harbor Court
Baltimore, 550 Light Street, Baltimore, MD
21202.
Contact Person: Estina E. Thompson, PhD,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–496–
5749, thompsone@mail.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Clinical Neuroscience and
Neurodegeneration Study Section.
Date: October 5–6, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Avenue, NW., Washington, DC 20037.
Contact Person: Seetha Bhagavan, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 435–
1121, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; SAT and
BTSS Member Conflict.
Date: October 5, 2009.
Time: 2 p.m. to 5 p.m.
VerDate Nov<24>2008
17:40 Sep 15, 2009
Jkt 217001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Roberto J. Matus, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7854, Bethesda, MD 20892, (301) 435–
2204, matusr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–22218 Filed 9–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel. SBIR.
Date: October 13, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health/
NCCAM, 6707 Democracy Blvd, Suite 401,
Bethesda, MD 20892. (Telephone Conference
Call)
Contact Person: Ray Bramhall, PhD,
Scientific Review Officer, National Center for
Complementary and Alternative Medicine,
6707 Democracy Blvd., Suite 401, Bethesda,
MD 20892. bramhallr@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel. Basic and
Preclinical Research and Career Development
Applications.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Date: October 19–20, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, Gaithersburg
Washingtonian Center, 204 Boardwalk Place,
Gaithersburg, MD 20878.
Contact Person: Peter Kozel, PhD,
Scientific Review Officer, NCCAM,6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892–5475. 301–496–8004.
kozelp@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel. Fellowship and
Training Applications.
Date: October 28, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Legacy Hotel and Meeting
Center, 1775 Rockville Pike, Rockville, MD
20852.
Contact Person: Peter Kozel, PhD,
Scientific Review Officer, NCCAM, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892–5475. 301–496–8004.
kozelp@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel. Clinical Science.
Date: October 29–30, 2009.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Laurie Friedman Donze,
PhD, Scientific Review Officer, Office of
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892. 301–402–1030.
donzel@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: September 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–22311 Filed 9–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2001–F–0049] (formerly
Docket No. 2001F–0047)
National Fisheries Institute; Filing of
Food Additive Petition; Amendment
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is amending the
E:\FR\FM\16SEN1.SGM
16SEN1
srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 74, No. 178 / Wednesday, September 16, 2009 / Notices
filing notice for a food additive petition
filed by the National Fisheries Institute,
to provide for the safe use of ionizing
radiation for control of foodborne
pathogens in crustaceans and processed
crustaceans.
FOR FURTHER INFORMATION CONTACT:
Lane A. Highbarger, Center for Food
Safety and Applied Nutrition (HFS–
255), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740, 301–436–1204.
SUPPLEMENTARY INFORMATION: Under the
Federal Food, Drug, and Cosmetic Act
(sec. 409(b)(5) (21 U.S.C. 348(b)(5))), a
notice was published in the Federal
Register of February 6, 2001 (66 FR
9086) announcing that a food additive
petition (FAP 1M4727) had been filed
by the National Fisheries Institute, 7918
Jones Branch Dr., McLean, VA 22102,
proposing that the food additive
regulations in part 179 Irradiation in the
Production, Processing and Handling of
Food (21 CFR part 179) be amended to
provide for the safe use of ionizing
radiation for control of foodborne
pathogens in raw-, frozen-, cooked-,
partially cooked-, shelled-, or dried
crustaceans, or cooked- or ready-to-cook
crustaceans processed with batter,
breading, spices, or small amounts of
other food ingredients.
Subsequent to the publication of the
filing notice, the National Fisheries
Institute amended the scope of their
petition so as to exclude the use of
breading or batter. FDA received a letter
from the National Fisheries Institute,
dated July 16, 2009, asking FDA to
modify the scope of the petition so that
breading and batter are not included.
Therefore, FDA is amending the filing
notice of February 6, 2001, to state that
the National Fisheries Institute is
proposing that the food additive
regulations in part 179 be amended to
provide for the use of ionizing radiation
for the control of foodborne pathogens
in raw-, frozen-, cooked-, partially
cooked-, shelled-, or dried-crustaceans
or cooked- or ready-to-cook crustaceans
processed with spices or small amounts
of other food ingredients.
The agency has determined under 21
CFR 25.32(i) that this action is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
Dated: September 4, 2009.
Laura M. Tarantino,
Director, Office of Food Safety, Center for
Food Safety and Applied Nutrition.
[FR Doc. E9–22008 Filed 9–15–09; 8:45 am]
BILLING CODE 4160–01–S
VerDate Nov<24>2008
17:40 Sep 15, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–057]
Request for Information on 1Bromopropane
AGENCY: National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of public comment
period.
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC) intends to
evaluate the scientific data on the
brominated organic solvent, 1Bromopropane (1–BP, CAS # 106–94–5,
also known as n-propyl bromide), and
develop appropriate communication
documents, such as a Current
Intelligence Bulletin, Criteria Document
and/or other informational products,
and establish a Recommended Exposure
Limit (REL) for 1–BP. NIOSH is
requesting information on the following:
(1) published and unpublished reports
and findings from in vitro and in vivo
toxicity studies with 1–BP, (2)
information on possible health effects
observed in workers exposed to 1–BP,
(3) information on workplaces and
products in which 1–BP can be found,
(4) description of work tasks and
scenarios with a potential for exposure
to 1–BP, (5) workplace exposure data,
and (6) information on control measures
(e.g., engineering controls, work
practices, personal protective
equipment) that are being used in
workplaces where potential exposures
to 1–BP occur.
Public Comment Period: Comments
must be received by December 14, 2009.
ADDRESSES: You may submit comments,
identified by docket number NIOSH–
057, by any of the following methods:
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 4676
Columbia Parkway, Cincinnati, OH
45226.
• Facsimile: (513) 533–8285.
• E-mail: nioshdocket@cdc.gov.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Cincinnati, Ohio 45226. A complete
electronic docket containing all
comments submitted will be available
on the NIOSH Web page at https://
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
47593
www.cdc.gov/niosh/docket, and
comments will be available in writing
by request. NIOSH includes all
comments received without change in
the docket, including any personal
information provided.
FOR FURTHER INFORMATION CONTACT: G.
Scott Dotson, PhD, NIOSH, Robert A
Taft Laboratories, MS–C32, 4676
Columbia Parkway, Cincinnati, OH
45226, telephone (513) 533–8540.
SUPPLEMENTARY INFORMATION: 1–BP is a
brominated organic solvent that has
received increased global attention in
recent years as a potential alternative for
ozone depleting substances and other
compounds with known adverse health
effects, such as chlorofluorocarbons
(CFC), hydrochlorofluorocarbons
(HCFC), and methylene chloroform. 1–
BP is used in multiple industrial
processes including vapor and
immersion degreasing operations, and
as a solvent in industries using aerosolapplied adhesives; 1–BP is also
proposed as a replacement solvent for
perchloroethylene in the dry-cleaning
sector. The National Toxicology
Program (NTP) estimated that
approximately 8.2 million pounds (lbs)
of 1–BP were used in the United States
(U.S.) in 2002. Estimates of the number
of workers exposed to 1–BP are
unavailable due to limited exposure
data and its relatively recent
introduction into domestic commerce.
The toxic nature of 1–BP is not fully
understood. Recently published case
reports describe possible adverse health
effects, including neurotoxicity,
following occupational exposures to 1–
BP. The findings of animal toxicity
studies in rats and mice indicate that 1–
BP may be a reproductive and
developmental toxicant, in addition a
neurotoxicant. No occupational
exposure limits for 1–BP have been
established by NIOSH or the
Occupational Safety and Health
Administration (OSHA).
NIOSH seeks to obtain materials,
including published and unpublished
reports and research findings, to
evaluate the possible health risks of
occupational exposure to 1–BP.
Examples of requested information
include, but are not limited to, the
following:
(1) Identification of industries or
occupations in which exposures to 1–BP
may occur.
(2) Trends in the production and use
of 1–BP and 1–BP containing
compounds.
(3) Description of work tasks and
scenarios with a potential for exposure
to 1–BP.
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 74, Number 178 (Wednesday, September 16, 2009)]
[Notices]
[Pages 47592-47593]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-22008]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2001-F-0049] (formerly Docket No. 2001F-0047)
National Fisheries Institute; Filing of Food Additive Petition;
Amendment
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the
[[Page 47593]]
filing notice for a food additive petition filed by the National
Fisheries Institute, to provide for the safe use of ionizing radiation
for control of foodborne pathogens in crustaceans and processed
crustaceans.
FOR FURTHER INFORMATION CONTACT: Lane A. Highbarger, Center for Food
Safety and Applied Nutrition (HFS-255), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740, 301-436-1204.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (sec. 409(b)(5) (21 U.S.C. 348(b)(5))), a notice was published in
the Federal Register of February 6, 2001 (66 FR 9086) announcing that a
food additive petition (FAP 1M4727) had been filed by the National
Fisheries Institute, 7918 Jones Branch Dr., McLean, VA 22102, proposing
that the food additive regulations in part 179 Irradiation in the
Production, Processing and Handling of Food (21 CFR part 179) be
amended to provide for the safe use of ionizing radiation for control
of foodborne pathogens in raw-, frozen-, cooked-, partially cooked-,
shelled-, or dried crustaceans, or cooked- or ready-to-cook crustaceans
processed with batter, breading, spices, or small amounts of other food
ingredients.
Subsequent to the publication of the filing notice, the National
Fisheries Institute amended the scope of their petition so as to
exclude the use of breading or batter. FDA received a letter from the
National Fisheries Institute, dated July 16, 2009, asking FDA to modify
the scope of the petition so that breading and batter are not included.
Therefore, FDA is amending the filing notice of February 6, 2001,
to state that the National Fisheries Institute is proposing that the
food additive regulations in part 179 be amended to provide for the use
of ionizing radiation for the control of foodborne pathogens in raw-,
frozen-, cooked-, partially cooked-, shelled-, or dried-crustaceans or
cooked- or ready-to-cook crustaceans processed with spices or small
amounts of other food ingredients.
The agency has determined under 21 CFR 25.32(i) that this action is
of a type that does not individually or cumulatively have a significant
effect on the human environment. Therefore, neither an environmental
assessment nor an environmental impact statement is required.
Dated: September 4, 2009.
Laura M. Tarantino,
Director, Office of Food Safety, Center for Food Safety and Applied
Nutrition.
[FR Doc. E9-22008 Filed 9-15-09; 8:45 am]
BILLING CODE 4160-01-S
